Skip to main content

Table 8 Baseline-reported outcome scores for SF-36 domains in adult patients

From: The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics

SF-36 Domain rhPTH(1-84)
(n=63)
Conventional therapy
(n=579)
Analysis populationa
(N=642)
n Value n Value n Value
Physical functioning 62 43±11.6 525 47±10.1 587 47±10.3
Bodily pain 62 44±10.4 530 47±10.8 592 47±10.8
Role limitation – physical health 62 42±11.4 527 46±11.0 589 46±11.1
Role limitation – emotional problems 62 42±14.4 530 47±11.1 592 47±11.6
General health 61 41±10.4 528 46±11.5 589 45±11.5
Mental health 61 45±12.0 529 49±10.2 590 49±10.5
Social functioning 61 42±11.1 530 47±10.9 591 46±11.0
Vitality 61 42±11.5 529 47±11.1 590 47±11.2
  1. All values are presented as mean ± SD
  2. rhPTH(1-84) recombinant human parathyroid hormone (1-84), SF-36 36-Item Short Form Health Survey questionnaire for adults
  3. aBaseline is defined as the assessment at enrollment (visit 1); pediatric patients (n=27) and those who initiated rhPTH(1-84) before enrollment (n=68) were excluded from the analysis